| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |